Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
40 participants
INTERVENTIONAL
2011-04-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414
Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
NCT02092649
Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes
NCT04327713
Omega-3 Fatty Acids and Insulin Sensitivity
NCT01686568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
diet only
low glycemic index diet, calorie restricted with exercise 3 times per week.
low glycemic diet
a low glycemic diet, calorie restricted with exercise sessions 3 times per week
supplemented
2000 IU vitamin D3 plus 1.8 g EPA + DHA
low glycemic diet
a low glycemic diet, calorie restricted with exercise sessions 3 times per week
vitamin D omega-3
2000 IU vitamin D3 plus 1.8 g EPA + DHA per day for 16 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low glycemic diet
a low glycemic diet, calorie restricted with exercise sessions 3 times per week
vitamin D omega-3
2000 IU vitamin D3 plus 1.8 g EPA + DHA per day for 16 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be able to swallow tablets and capsules
* must be 18 years of age or older
* must be physically capable of moderate intensity exercise
Exclusion Criteria
* vegetarian
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Guelph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelly Anne Meckling, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelly A Meckling, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Guelph
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Guelph
Guelph, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011MeckVitD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.